Literature DB >> 1355794

HIV-associated oral lesions; immunologic, virologic and salivary parameters.

C E Barr1, M R Lopez, A Rua-Dobles, L K Miller, U Mathur-Wagh, L R Turgeon.   

Abstract

There are numerous reports of oral lesions in HIV-infected individuals. However, few correlate the oral lesions with laboratory parameters. This study examined oral candidiasis and hairy leukoplakia, the two most common HIV-associated oral lesions, in relation to T-cell counts, p24 core antigen levels and salivary flow rates. Oral mucosal examinations, immunologic and virologic studies and stimulated whole and parotid saliva flow rates were conducted on 135 (HIV+ = 102, HIV- = 33) homosexual or bisexual men. Results indicate that, among HIV-infected subjects, the odds of having oral candidiasis is 6 times (95% CI = 0.6-56.6) greater for subjects with T4 counts between 200-399 per mm3, and 23 times (95% CI = 2.8-193.0) greater for subjects with T4 counts less than 200/mm3 compared to subjects with T4 counts of 400/mm3 or greater. Subjects had an equal likelihood of having hairy leukoplakia at different levels of immunocompetence. The prevalence of oral candidiasis and hairy leukoplakia was higher among subjects with infectious virus in their serum, but was only statistically significant for hairy leukoplakia (p = 0.01).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355794     DOI: 10.1111/j.1600-0714.1992.tb01014.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  3 in total

1.  Submandibular gland infection by Mycobacterium avium-intracellulare in an AIDS patient.

Authors:  J Elvira; E García del Río; A López-Suárez; P García-Martos; J A Girón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

2.  Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.

Authors:  C H Shiboski; H Chen; M A Ghannoum; L Komarow; S Evans; P K Mukherjee; N Isham; D Katzenstein; A Asmelash; A E Omozoarhe; S Gengiah; R Allen; S Tripathy; S Swindells
Journal:  Int J Tuberc Lung Dis       Date:  2014-06       Impact factor: 2.373

3.  Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use.

Authors:  Courtney L C Collins; Thomas Kerr; Laura M Kuyper; Kathy Li; Mark W Tyndall; David C Marsh; Julio S Montaner; Evan Wood
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.